• KL1333 receives FDA ODD for mitochondrial diseases europeanpharmaceuticalreview
    April 24, 2018
    NeuroVive Pharmaceutical AB has been granted Orphan Drug Designation for its project KL1333 for treatment of inherited mitochondrial respiratory chain diseases…
PharmaSources Customer Service